Agile Therapeutics, Inc. (AGRX)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
Show:
Annual
Income Statement
All numbers in thousandsBreakdown
ttm
2020-12-31
2019-12-31
2018-12-31
2017-12-31
Total Revenue
3,336
749
0
0
0
Cost of Revenue
5,299
282
-
-
-
Gross Profit
-1,963
467
-
-
-
Operating Expenses
Research Development
7,580
13,500
9,858
9,777
14,428
Selling General and Administrative
55,845
36,020
9,000
8,739
12,383
Total Operating Expenses
63,425
49,520
18,858
18,516
26,811
Operating Income or Loss
-65,388
-49,053
-18,858
-18,516
-26,811
Interest Expense
3,818
3,109
0
1,116
1,918
Total Other Income/Expenses Net
-
-
-
-990
143
Income Before Tax
-69,157
-51,853
-18,606
-20,256
-28,304
Income Tax Expense
0
0
0
-477
0
Income from Continuing Operations
-69,157
-51,853
-18,606
-19,779
-28,304
Net Income
-69,157
-51,853
-18,606
-19,779
-28,304
Net Income available to common shareholders
-69,157
-51,853
-18,606
-19,779
-28,304
Basic EPS
-
-0.61
-0.38
-0.58
-0.91
Diluted EPS
-
-0.61
-0.38
-0.58
-0.91
Basic Average Shares
-
84,683
49,432
34,316
30,941
Diluted Average Shares
-
84,683
49,432
34,316
30,941
EBITDA
-
-48,468
-18,443
-19,117
-26,363
